Cahill Financial Advisors Inc Landos Biopharma, Inc. Transaction History

Cahill Financial Advisors Inc

  • $717 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$4.7 - $15.0 $470 - $1,500
-100 Closed
0 $0
Q3 2021

Nov 16, 2021
BUY
$9.77 - $15.77 $977 - $1,577
100 New
100 $1,000

About Landos Biopharma, Inc.

LABP Quotes by TradingView
  • Ticker LABP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,254,900
  • Description
  • Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...
More about LABP
Track This Portfolio

Track Cahill Financial Advisors Inc Portfolio

Follow Cahill Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cahill Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cahill Financial Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email